ChemoCentryx
CCXI
#3635
Rank
HK$29.15 B
Marketcap
HK$405.33
Share price
0.00%
Change (1 day)
33.93%
Change (1 year)

EPS for ChemoCentryx (CCXI)

EPS in 2022 (TTM): -HK$14.78

According to ChemoCentryx's latest financial reports the company's current EPS (TTM) is -HK$14.73. In 2021 the company made an earnings per share (EPS) of -HK$14.73 a decrease over its 2020 EPS that were of -HK$6.31.

EPS history for ChemoCentryx from 2012 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$14.780.27%
2021-HK$14.73133.33%
2020-HK$6.31-16.49%
2019-HK$7.5627.63%
2018-HK$5.93-305.41%
2017HK$2.88-142.53%
2016-HK$6.78-19.44%
2015-HK$8.42-0%
2014-HK$8.4213.68%
2013-HK$7.41-16.67%
2012-HK$8.89

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Biogen
BIIB
HK$85.68-681.48%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
HK$10.54-171.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$28.03-290.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Bristol-Myers Squibb
BMY
HK$23.15-257.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$81.39-652.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.59-789.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.41-191.01%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
HK$4.91-133.33%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Merck
MRK
HK$59.20-501.79%๐Ÿ‡บ๐Ÿ‡ธ USA